Prevalence and Impact of Obstructive Sleep Apnea in Multiple Sclerosis

Part of paid clinical trials in Boston, Massachusetts.

Sponsor
Beth Israel Deaconess Medical Center
Study ID
NCT04603196
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

This study will evaluate the influence of sleep apnea on clinical and radiological features of MS. Sleep apnea is associated with hypoxemia during sleep, which is likely detrimental to MS. Clinical data (MRI, lab results, medical history, labs, and sleep studies) of MS patients will be collected and analyzed. This will be done to study correlations between MRI, clinical data, lab studies and sleep studies. There is specific interest in the type of sleep apnea associated with MS, and whether MRI or clinical metrics of MS severity correlate with presence or absence of sleep apnea.

Key Dates

Start date
Jun 20, 2019
Status verified
May 2026
Primary completion
Jun 20, 2026
Completion
Jun 20, 2030

Study Design

Enrollment
800 participants (estimated)

Arms

  • Arm: Patients with Multiple Sclerosis with obstructive sleep apnea
    Patients with Multiple Sclerosis with obstructive sleep apnea
  • Arm: Patients with MS without obstructive sleep apnea
    Patients with MS without obstructive sleep apnea

Primary Outcome Measure

Home Sleep Study Data [ Time Frame: 1 year ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Beth Israel Deaconess Medical CenterBostonMassachusetts02215
Jacob sloane
[email protected]
617-667-3726
[email protected]
Jacob Sloane, MD, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Boston, MA

By condition
Multiple sclerosis
By specialty
NeurologyBrain disordersAutoimmune disease
By research site
Beth Israel Deaconess Medical Center· Boston, MA

Related Studies